ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print April 12, 2006, 10.1183/09031936.06.00116205
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/1/113    most recent
09031936.06.00116205v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zandvoort, A.
Right arrow Articles by Postma, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zandvoort, A.
Right arrow Articles by Postma, D. S.
Eur Respir J 2006; 28:113-122
Copyright ©ERS Journals Ltd 2006

High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function

A. Zandvoort1,2, Y. M. van der Geld1, M. R. Jonker1,2, J. A. Noordhoek2, J. T. W. M. Vos1, J. Wesseling1, H. F. Kauffman3, W. Timens1 and D. S. Postma2

1 Depts of Pathology and Laboratory Medicine, 2 Pulmonology and, 3 Allergology, University Medical Center Groningen, University of Groningen, The Netherlands.

CORRESPONDENCE: W. Timens, University Medical Center Groningen, Dept of Pathology and Laboratory Medicine, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Fax: 31 503632510. E-mail: w.timens{at}path.umcg.nl

Keywords: CD8+ T-cells, chronic inflammation, chronic obstructive pulmonary disease, intracellular adhesion molecule-1, lung fibroblasts

Received: October 5, 2005
Accepted March 21, 2006

Chronic obstructive pulmonary disease (COPD) is characterised by destruction of extracellular matrix (ECM) in parenchymal areas, whereas the bronchial walls can show fibrosis. In addition, an extensive inflammatory process is observed. CD8+ T-cells, located throughout the lung, and epithelial cells in centrally located airways, produce cytokines involved in the inflammatory process. These cytokines may influence the present fibroblasts, the key effectors in the defective ECM repair and maintenance in COPD.

The current authors explored the effects of the cytokine microenvironment on cell–cell interaction gene expression in pulmonary fibroblasts of controls (n = 6), and Global Initiative for Chronic Obstructive Lung Disease stage II (n = 7) and stage IV (n = 7) COPD patients. The current authors simulated the in vivo microenvironment using supernatants of CD3/CD28 stimulated CD8+ T-cells isolated from peripheral blood of COPD patients, supernatant of a bronchial-epithelial cell line, or a combination of both.

The present data show that fibroblasts of chronic obstructive pulmonary disease patients display an altered response to the cytokine microenvironment, depending on both the disease stage and the central or peripheral location in the lung. Especially adhesion-related genes are upregulated in fibroblasts of chronic obstructive pulmonary disease patients, which can indicate a more pronounced role of fibroblasts in the inflammatory process in chronic obstructive pulmonary disease, possibly resulting in reduced function as effectors of extracellular matrix repair.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
K. F. Rabe, B. Beghe, F. Luppi, and L. M. Fabbri
Update in Chronic Obstructive Pulmonary Disease 2006
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1222 - 1232.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.